BioSpace News Archive

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor’s Business Daily.

AtriCure, Inc. announced that it will release its fourth quarter and full year 2019 financial results on Tuesday, February 18, 2020.

Group sales revenue up 14.8%; order intake up 14.8%; underlying EBITDA margin 27.1%

Screenings available on select Thursdays in February at MinuteClinic locations nationwide

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXD), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, is pleased to announce that the data of its clinical studies with its lead product candidate, Bria-IMT™, will be presented the at the Annual Symposium of Society of Surgical Oncology (SSO) 2020

Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool

The CEO of Co-Diagnostics, Inc. (Nasdaq:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, was interviewed by the host of CNBC Squawk Box Asia last night, to discuss the current outbreak of the novel coronavirus that originated in China

Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least 200,000 KwikPens® to three relief organizations – Americares, Direct Relief and Dispensary of Hope – to stock insulin at nearly 200 U.S. free clinics through 2022.

Encompass Health Corp. and the University of Iowa Health System, the nonprofit corporation that supports the clinical, academic and research programs of University of Iowa Health Care, announced they have entered into an agreement to jointly own a 40-bed, freestanding inpatient rehabilitation hospital currently under construction in Coralville, Iowa..

Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today reported financial results for the second quarter and first six months of fiscal year 2020 ended December 31, 2019.